HEADER IMMUNE SYSTEM 01-MAY-17 5XJF TITLE CRYSTAL STRUCTURE OF FUCOSYLATED IGG FC Y296W MUTANT COMPLEXED WITH TITLE 2 BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 227-449; COMPND 5 SYNONYM: IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN NIE; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: FC FRAGMENT; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: LOW AFFINITY IMMUNOGLOBULIN GAMMA FC REGION RECEPTOR III-A; COMPND 11 CHAIN: C; COMPND 12 FRAGMENT: UNP RESIDUES 21-193; COMPND 13 SYNONYM: CD16A ANTIGEN,FC-GAMMA RIII-ALPHA,FCRIIIA,FCR-10,IGG FC COMPND 14 RECEPTOR III-2; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: MS704; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PKANTEX2160; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: FCGR3A, CD16A, FCG3, FCGR3, IGFR3; SOURCE 15 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PKANTEX93 KEYWDS IMMUNE SYSTEM, COMPLEX, FC FRAGMENT, IGG, RECEPTOR, CD16, GAMMA EXPDTA X-RAY DIFFRACTION AUTHOR Y.SAKAE,T.SATOH,H.YAGI,S.YANAKA,T.YAMAGUCHI,Y.ISODA,S.IIDA,Y.OKAMOTO, AUTHOR 2 K.KATO REVDAT 4 23-OCT-24 5XJF 1 REMARK REVDAT 3 22-NOV-23 5XJF 1 HETSYN LINK REVDAT 2 29-JUL-20 5XJF 1 COMPND REMARK HETNAM LINK REVDAT 2 2 1 SITE ATOM REVDAT 1 01-NOV-17 5XJF 0 JRNL AUTH Y.SAKAE,T.SATOH,H.YAGI,S.YANAKA,T.YAMAGUCHI,Y.ISODA,S.IIDA, JRNL AUTH 2 Y.OKAMOTO,K.KATO JRNL TITL CONFORMATIONAL EFFECTS OF N-GLYCAN CORE FUCOSYLATION OF JRNL TITL 2 IMMUNOGLOBULIN G FC REGION ON ITS INTERACTION WITH FC GAMMA JRNL TITL 3 RECEPTOR IIIA. JRNL REF SCI REP V. 7 13780 2017 JRNL REFN ESSN 2045-2322 JRNL PMID 29062024 JRNL DOI 10.1038/S41598-017-13845-8 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 35921 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1890 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.57 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2491 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.62 REMARK 3 BIN R VALUE (WORKING SET) : 0.3690 REMARK 3 BIN FREE R VALUE SET COUNT : 131 REMARK 3 BIN FREE R VALUE : 0.4350 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4653 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 299 REMARK 3 SOLVENT ATOMS : 109 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 66.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.50000 REMARK 3 B22 (A**2) : 0.50000 REMARK 3 B33 (A**2) : -1.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.319 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.258 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.212 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.768 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5111 ; 0.011 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4531 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6997 ; 1.609 ; 2.018 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10666 ; 0.948 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 573 ; 6.761 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 216 ;37.976 ;24.722 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 804 ;16.086 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;14.742 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 830 ; 0.178 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5285 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 942 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2310 ; 4.098 ; 6.434 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2309 ; 4.098 ; 6.432 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2877 ; 6.201 ; 9.619 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2878 ; 6.200 ; 9.621 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2800 ; 4.345 ; 7.126 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2801 ; 4.344 ; 7.129 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 4121 ; 6.878 ;10.531 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5083 ; 9.294 ;73.798 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5084 ; 9.295 ;73.806 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5XJF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-MAY-17. REMARK 100 THE DEPOSITION ID IS D_1300003625. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-FEB-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-5A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37895 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 46.550 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 13.50 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9 REMARK 200 DATA REDUNDANCY IN SHELL : 11.80 REMARK 200 R MERGE FOR SHELL (I) : 0.90200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3AY4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 20000, 0.1 M MES (PH 6.5), 4% REMARK 280 ZWITTERGENT 3-14, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 174.90000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 38.65000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 38.65000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.45000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 38.65000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 38.65000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 262.35000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 38.65000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 38.65000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 87.45000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 38.65000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 38.65000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 262.35000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 174.90000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 225 REMARK 465 CYS A 226 REMARK 465 PRO A 227 REMARK 465 PRO A 228 REMARK 465 CYS A 229 REMARK 465 PRO A 445 REMARK 465 GLY A 446 REMARK 465 LYS A 447 REMARK 465 THR B 225 REMARK 465 CYS B 226 REMARK 465 PRO B 227 REMARK 465 PRO B 228 REMARK 465 CYS B 229 REMARK 465 PRO B 445 REMARK 465 GLY B 446 REMARK 465 LYS B 447 REMARK 465 GLU C 3 REMARK 465 ASP C 4 REMARK 465 LEU C 5 REMARK 465 PRO C 6 REMARK 465 LYS C 7 REMARK 465 ALA C 8 REMARK 465 VAL C 9 REMARK 465 GLY C 31 REMARK 465 ALA C 32 REMARK 465 TYR C 33 REMARK 465 SER C 34 REMARK 465 PRO C 35 REMARK 465 GLU C 36 REMARK 465 ASP C 37 REMARK 465 GLN C 38 REMARK 465 SER C 39 REMARK 465 THR C 40 REMARK 465 GLN C 41 REMARK 465 ALA C 53 REMARK 465 SER C 54 REMARK 465 SER C 55 REMARK 465 GLN C 74 REMARK 465 LEU C 75 REMARK 465 GLY C 175 REMARK 465 HIS C 176 REMARK 465 HIS C 177 REMARK 465 HIS C 178 REMARK 465 HIS C 179 REMARK 465 HIS C 180 REMARK 465 HIS C 181 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 285 -148.24 -115.43 REMARK 500 ASN A 286 -14.24 68.12 REMARK 500 LEU A 358 -8.51 -59.52 REMARK 500 PRO A 374 -178.42 -68.69 REMARK 500 ASP B 270 70.02 -119.10 REMARK 500 LYS C 22 3.43 81.10 REMARK 500 GLU C 46 73.92 52.82 REMARK 500 ALA C 61 150.68 -49.12 REMARK 500 GLN C 72 145.65 -171.83 REMARK 500 GLU C 103 -6.96 75.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1139 DISTANCE = 6.25 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5XJE RELATED DB: PDB DBREF 5XJF A 225 447 UNP P0DOX5 IGG1_HUMAN 227 449 DBREF 5XJF B 225 447 UNP P0DOX5 IGG1_HUMAN 227 449 DBREF 5XJF C 3 175 UNP P08637 FCG3A_HUMAN 21 193 SEQADV 5XJF TRP A 296 UNP P0DOX5 TYR 298 ENGINEERED MUTATION SEQADV 5XJF TRP B 296 UNP P0DOX5 TYR 298 ENGINEERED MUTATION SEQADV 5XJF GLN C 38 UNP P08637 ASN 56 ENGINEERED MUTATION SEQADV 5XJF GLN C 74 UNP P08637 ASN 92 ENGINEERED MUTATION SEQADV 5XJF VAL C 158 UNP P08637 PHE 176 ENGINEERED MUTATION SEQADV 5XJF GLN C 169 UNP P08637 ASN 187 ENGINEERED MUTATION SEQADV 5XJF HIS C 176 UNP P08637 EXPRESSION TAG SEQADV 5XJF HIS C 177 UNP P08637 EXPRESSION TAG SEQADV 5XJF HIS C 178 UNP P08637 EXPRESSION TAG SEQADV 5XJF HIS C 179 UNP P08637 EXPRESSION TAG SEQADV 5XJF HIS C 180 UNP P08637 EXPRESSION TAG SEQADV 5XJF HIS C 181 UNP P08637 EXPRESSION TAG SEQRES 1 A 223 THR CYS PRO PRO CYS PRO ALA PRO GLU LEU LEU GLY GLY SEQRES 2 A 223 PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS ASP THR SEQRES 3 A 223 LEU MET ILE SER ARG THR PRO GLU VAL THR CYS VAL VAL SEQRES 4 A 223 VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS PHE ASN SEQRES 5 A 223 TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA LYS THR SEQRES 6 A 223 LYS PRO ARG GLU GLU GLN TRP ASN SER THR TYR ARG VAL SEQRES 7 A 223 VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP LEU ASN SEQRES 8 A 223 GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS ALA LEU SEQRES 9 A 223 PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA LYS GLY SEQRES 10 A 223 GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO PRO SER SEQRES 11 A 223 ARG ASP GLU LEU THR LYS ASN GLN VAL SER LEU THR CYS SEQRES 12 A 223 LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA VAL GLU SEQRES 13 A 223 TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR LYS THR SEQRES 14 A 223 THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE PHE LEU SEQRES 15 A 223 TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP GLN GLN SEQRES 16 A 223 GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU ALA LEU SEQRES 17 A 223 HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SER PRO SEQRES 18 A 223 GLY LYS SEQRES 1 B 223 THR CYS PRO PRO CYS PRO ALA PRO GLU LEU LEU GLY GLY SEQRES 2 B 223 PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS ASP THR SEQRES 3 B 223 LEU MET ILE SER ARG THR PRO GLU VAL THR CYS VAL VAL SEQRES 4 B 223 VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS PHE ASN SEQRES 5 B 223 TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA LYS THR SEQRES 6 B 223 LYS PRO ARG GLU GLU GLN TRP ASN SER THR TYR ARG VAL SEQRES 7 B 223 VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP LEU ASN SEQRES 8 B 223 GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS ALA LEU SEQRES 9 B 223 PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA LYS GLY SEQRES 10 B 223 GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO PRO SER SEQRES 11 B 223 ARG ASP GLU LEU THR LYS ASN GLN VAL SER LEU THR CYS SEQRES 12 B 223 LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA VAL GLU SEQRES 13 B 223 TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR LYS THR SEQRES 14 B 223 THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE PHE LEU SEQRES 15 B 223 TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP GLN GLN SEQRES 16 B 223 GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU ALA LEU SEQRES 17 B 223 HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SER PRO SEQRES 18 B 223 GLY LYS SEQRES 1 C 179 GLU ASP LEU PRO LYS ALA VAL VAL PHE LEU GLU PRO GLN SEQRES 2 C 179 TRP TYR ARG VAL LEU GLU LYS ASP SER VAL THR LEU LYS SEQRES 3 C 179 CYS GLN GLY ALA TYR SER PRO GLU ASP GLN SER THR GLN SEQRES 4 C 179 TRP PHE HIS ASN GLU SER LEU ILE SER SER GLN ALA SER SEQRES 5 C 179 SER TYR PHE ILE ASP ALA ALA THR VAL ASP ASP SER GLY SEQRES 6 C 179 GLU TYR ARG CYS GLN THR GLN LEU SER THR LEU SER ASP SEQRES 7 C 179 PRO VAL GLN LEU GLU VAL HIS ILE GLY TRP LEU LEU LEU SEQRES 8 C 179 GLN ALA PRO ARG TRP VAL PHE LYS GLU GLU ASP PRO ILE SEQRES 9 C 179 HIS LEU ARG CYS HIS SER TRP LYS ASN THR ALA LEU HIS SEQRES 10 C 179 LYS VAL THR TYR LEU GLN ASN GLY LYS GLY ARG LYS TYR SEQRES 11 C 179 PHE HIS HIS ASN SER ASP PHE TYR ILE PRO LYS ALA THR SEQRES 12 C 179 LEU LYS ASP SER GLY SER TYR PHE CYS ARG GLY LEU VAL SEQRES 13 C 179 GLY SER LYS ASN VAL SER SER GLU THR VAL GLN ILE THR SEQRES 14 C 179 ILE THR GLN GLY HIS HIS HIS HIS HIS HIS HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET MAN D 4 11 HET NAG D 5 14 HET GAL D 6 11 HET MAN D 7 11 HET NAG D 8 14 HET FUC D 9 10 HET NAG E 1 14 HET NAG E 2 14 HET BMA E 3 11 HET MAN E 4 11 HET NAG E 5 14 HET GAL E 6 11 HET MAN E 7 11 HET NAG E 8 14 HET FUC E 9 10 HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HET MAN F 4 11 HET NAG F 5 14 HET CL A1010 1 HET NAG C1001 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 4 NAG 12(C8 H15 N O6) FORMUL 4 BMA 3(C6 H12 O6) FORMUL 4 MAN 5(C6 H12 O6) FORMUL 4 GAL 2(C6 H12 O6) FORMUL 4 FUC 2(C6 H12 O5) FORMUL 7 CL CL 1- FORMUL 9 HOH *109(H2 O) HELIX 1 AA1 LYS A 246 MET A 252 1 7 HELIX 2 AA2 LEU A 309 ASN A 315 1 7 HELIX 3 AA3 SER A 354 LYS A 360 5 7 HELIX 4 AA4 LYS A 414 GLN A 419 1 6 HELIX 5 AA5 LEU A 432 TYR A 436 5 5 HELIX 6 AA6 LYS B 246 MET B 252 1 7 HELIX 7 AA7 LEU B 309 ASN B 315 1 7 HELIX 8 AA8 SER B 354 LEU B 358 5 5 HELIX 9 AA9 LYS B 414 GLN B 419 1 6 HELIX 10 AB1 LEU B 432 TYR B 436 5 5 HELIX 11 AB2 THR C 62 SER C 66 5 5 HELIX 12 AB3 LYS C 114 THR C 116 5 3 HELIX 13 AB4 THR C 145 SER C 149 5 5 SHEET 1 AA1 4 SER A 239 PHE A 243 0 SHEET 2 AA1 4 GLU A 258 VAL A 266 -1 O VAL A 262 N PHE A 241 SHEET 3 AA1 4 TYR A 300 THR A 307 -1 O TYR A 300 N VAL A 266 SHEET 4 AA1 4 LYS A 288 THR A 289 -1 N LYS A 288 O VAL A 305 SHEET 1 AA2 4 SER A 239 PHE A 243 0 SHEET 2 AA2 4 GLU A 258 VAL A 266 -1 O VAL A 262 N PHE A 241 SHEET 3 AA2 4 TYR A 300 THR A 307 -1 O TYR A 300 N VAL A 266 SHEET 4 AA2 4 GLU A 293 GLU A 294 -1 N GLU A 293 O ARG A 301 SHEET 1 AA3 4 VAL A 282 VAL A 284 0 SHEET 2 AA3 4 LYS A 274 VAL A 279 -1 N TRP A 277 O VAL A 284 SHEET 3 AA3 4 TYR A 319 SER A 324 -1 O LYS A 322 N ASN A 276 SHEET 4 AA3 4 ILE A 332 ILE A 336 -1 O ILE A 332 N VAL A 323 SHEET 1 AA4 4 GLN A 347 LEU A 351 0 SHEET 2 AA4 4 GLN A 362 PHE A 372 -1 O LEU A 368 N TYR A 349 SHEET 3 AA4 4 PHE A 404 ASP A 413 -1 O LEU A 410 N LEU A 365 SHEET 4 AA4 4 TYR A 391 THR A 393 -1 N LYS A 392 O LYS A 409 SHEET 1 AA5 4 GLN A 347 LEU A 351 0 SHEET 2 AA5 4 GLN A 362 PHE A 372 -1 O LEU A 368 N TYR A 349 SHEET 3 AA5 4 PHE A 404 ASP A 413 -1 O LEU A 410 N LEU A 365 SHEET 4 AA5 4 VAL A 397 LEU A 398 -1 N VAL A 397 O PHE A 405 SHEET 1 AA6 4 GLN A 386 PRO A 387 0 SHEET 2 AA6 4 ALA A 378 SER A 383 -1 N SER A 383 O GLN A 386 SHEET 3 AA6 4 PHE A 423 MET A 428 -1 O SER A 426 N GLU A 380 SHEET 4 AA6 4 THR A 437 LEU A 441 -1 O LEU A 441 N PHE A 423 SHEET 1 AA7 4 SER B 239 PHE B 243 0 SHEET 2 AA7 4 GLU B 258 VAL B 266 -1 O THR B 260 N PHE B 243 SHEET 3 AA7 4 TYR B 300 THR B 307 -1 O LEU B 306 N VAL B 259 SHEET 4 AA7 4 LYS B 288 THR B 289 -1 N LYS B 288 O VAL B 305 SHEET 1 AA8 4 SER B 239 PHE B 243 0 SHEET 2 AA8 4 GLU B 258 VAL B 266 -1 O THR B 260 N PHE B 243 SHEET 3 AA8 4 TYR B 300 THR B 307 -1 O LEU B 306 N VAL B 259 SHEET 4 AA8 4 GLU B 293 GLU B 294 -1 N GLU B 293 O ARG B 301 SHEET 1 AA9 4 VAL B 282 VAL B 284 0 SHEET 2 AA9 4 LYS B 274 VAL B 279 -1 N VAL B 279 O VAL B 282 SHEET 3 AA9 4 TYR B 319 SER B 324 -1 O LYS B 322 N ASN B 276 SHEET 4 AA9 4 ILE B 332 ILE B 336 -1 O ILE B 332 N VAL B 323 SHEET 1 AB1 4 GLN B 347 LEU B 351 0 SHEET 2 AB1 4 GLN B 362 PHE B 372 -1 O LYS B 370 N GLN B 347 SHEET 3 AB1 4 PHE B 404 ASP B 413 -1 O LEU B 410 N LEU B 365 SHEET 4 AB1 4 TYR B 391 THR B 393 -1 N LYS B 392 O LYS B 409 SHEET 1 AB2 4 GLN B 347 LEU B 351 0 SHEET 2 AB2 4 GLN B 362 PHE B 372 -1 O LYS B 370 N GLN B 347 SHEET 3 AB2 4 PHE B 404 ASP B 413 -1 O LEU B 410 N LEU B 365 SHEET 4 AB2 4 VAL B 397 LEU B 398 -1 N VAL B 397 O PHE B 405 SHEET 1 AB3 4 GLN B 386 GLU B 388 0 SHEET 2 AB3 4 ALA B 378 SER B 383 -1 N TRP B 381 O GLU B 388 SHEET 3 AB3 4 PHE B 423 MET B 428 -1 O SER B 426 N GLU B 380 SHEET 4 AB3 4 THR B 437 LEU B 441 -1 O LYS B 439 N CYS B 425 SHEET 1 AB4 3 PHE C 11 GLU C 13 0 SHEET 2 AB4 3 VAL C 25 LYS C 28 -1 O LYS C 28 N PHE C 11 SHEET 3 AB4 3 PHE C 57 ILE C 58 -1 O ILE C 58 N VAL C 25 SHEET 1 AB5 4 ARG C 18 LEU C 20 0 SHEET 2 AB5 4 VAL C 82 HIS C 87 1 O GLU C 85 N VAL C 19 SHEET 3 AB5 4 GLY C 67 ARG C 70 -1 N TYR C 69 O VAL C 82 SHEET 4 AB5 4 PHE C 43 HIS C 44 -1 N PHE C 43 O ARG C 70 SHEET 1 AB6 3 LEU C 91 GLN C 94 0 SHEET 2 AB6 3 ILE C 106 SER C 112 -1 O ARG C 109 N GLN C 94 SHEET 3 AB6 3 PHE C 139 ILE C 141 -1 O ILE C 141 N ILE C 106 SHEET 1 AB7 5 VAL C 99 LYS C 101 0 SHEET 2 AB7 5 VAL C 168 THR C 173 1 O THR C 173 N PHE C 100 SHEET 3 AB7 5 GLY C 150 VAL C 158 -1 N TYR C 152 O VAL C 168 SHEET 4 AB7 5 HIS C 119 GLN C 125 -1 N HIS C 119 O LEU C 157 SHEET 5 AB7 5 LYS C 128 HIS C 135 -1 O ARG C 130 N TYR C 123 SHEET 1 AB8 4 VAL C 99 LYS C 101 0 SHEET 2 AB8 4 VAL C 168 THR C 173 1 O THR C 173 N PHE C 100 SHEET 3 AB8 4 GLY C 150 VAL C 158 -1 N TYR C 152 O VAL C 168 SHEET 4 AB8 4 LYS C 161 SER C 164 -1 O LYS C 161 N VAL C 158 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.02 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.05 SSBOND 3 CYS B 261 CYS B 321 1555 1555 2.04 SSBOND 4 CYS B 367 CYS B 425 1555 1555 2.04 SSBOND 5 CYS C 29 CYS C 71 1555 1555 2.04 SSBOND 6 CYS C 110 CYS C 154 1555 1555 2.07 LINK ND2 ASN A 297 C1 NAG D 1 1555 1555 1.45 LINK ND2 ASN B 297 C1 NAG E 1 1555 1555 1.45 LINK ND2 ASN C 45 C1 NAG F 1 1555 1555 1.45 LINK ND2 ASN C 162 C1 NAG C1001 1555 1555 1.45 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.42 LINK O6 NAG D 1 C1 FUC D 9 1555 1555 1.42 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.44 LINK O6 BMA D 3 C1 MAN D 4 1555 1555 1.41 LINK O3 BMA D 3 C1 MAN D 7 1555 1555 1.43 LINK O2 MAN D 4 C1 NAG D 5 1555 1555 1.42 LINK O4 NAG D 5 C1 GAL D 6 1555 1555 1.45 LINK O2 MAN D 7 C1 NAG D 8 1555 1555 1.44 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.43 LINK O6 NAG E 1 C1 FUC E 9 1555 1555 1.40 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.43 LINK O6 BMA E 3 C1 MAN E 4 1555 1555 1.43 LINK O3 BMA E 3 C1 MAN E 7 1555 1555 1.44 LINK O2 MAN E 4 C1 NAG E 5 1555 1555 1.42 LINK O4 NAG E 5 C1 GAL E 6 1555 1555 1.45 LINK O2 MAN E 7 C1 NAG E 8 1555 1555 1.44 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.46 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.46 LINK O3 BMA F 3 C1 MAN F 4 1555 1555 1.46 LINK O2 MAN F 4 C1 NAG F 5 1555 1555 1.45 CISPEP 1 TYR A 373 PRO A 374 0 -10.73 CISPEP 2 TYR B 373 PRO B 374 0 -13.78 CISPEP 3 GLU C 13 PRO C 14 0 7.19 CRYST1 77.300 77.300 349.800 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012937 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012937 0.000000 0.00000 SCALE3 0.000000 0.000000 0.002859 0.00000